Skip to content

Clinical trials

Scleroderma, Systemic trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Country / region: Mexico Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20154
20161
20171
20223
20232
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting3
Recruiting3
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
Coordinación de Investigación en Salud, Mexico3
Amgen1
AstraZeneca1
GlaxoSmithKline1
Hoffmann-La Roche1
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran1
Pfizer1
Prolium Bioscience, Inc1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic16
Scleroderma, Diffuse6
Lung Diseases, Interstitial4
Autoimmune Diseases2
Immune System Diseases2
Peripheral Vascular Diseases1
Raynaud Disease1
Skin Diseases1
Vitamin D Deficiency1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.